To analyze and compare the effect of implantable intravenous infusion port and Peripherally Inserted Central Catheter(PICC)in patients with ovarian cancer undergoing chemotherapy.

A total of 80 patients with ovarian cancer treated in this hospital from January 2018 to December 2019 were randomly divided into control group (n=40) and study group (n=40). Both groups were treated with chemotherapy.During chemotherapy, the control group was treated with intravenous chemotherapy with PICC, and the study group was treated with intravenous chemotherapy with implantable intravenous infusion port.The success rate of one-time catheterization, the time spent in catheterization, the time of catheter indwelling and the incidence of complications during catheter indwelling were compared between the two groups.

The success rate of primary catheterization in the control group (95.00%) was significantly higher than that in the study group (80.00%), and the difference was statistically significant(P<0.05). The time of catheterization (37.16 ±3.07) minutes and catheter indwelling(13.55±1.08)days were significantly longer than those in the control group (20.18±2.32) minutes, (7.14 ±0.86)days, and the differences were statistically significant(P<0.05). The incidence of complications during catheter indwelling in the study group (7.50%) was significantly lower than that in the control group (30.00%), and the difference was statistically significant(P<0.05).

Port of implantable venous infusion in patients with ovarian cancer chemotherapy and PICC have their respective advantages.PICC has the advantages of simple operation and high success rate of catheterization, while the implantable intravenous infusion port has the advantages of long indwelling time and less complications, so the appropriate intravenous chemotherapy route can be selected according to the actual situation of patients.

Implantable venous transfusion port; Peripherally inserted central catheter; Ovarian cancer; Chemotherapy; Application effect